Supplementary MaterialsSupplementary Information 41467_2018_3133_MOESM1_ESM. show ARVIN outperforms state-of-the-art methods that use sequence-based features alone. Additional experimental validation using reporter assay further demonstrates the accuracy of ARVIN. Application of ARVIN to seven autoimmune diseases provides a holistic view of the gene subnetwork perturbed by the combinatorial action of the entire set of risk noncoding mutations. Introduction… Continue reading Supplementary MaterialsSupplementary Information 41467_2018_3133_MOESM1_ESM. show ARVIN outperforms state-of-the-art methods that use